Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CLELAND

Showing results (521-530 of 663) with videos related to

Pageof 67
Sort By:
Plos Medicine|May 22, 2019
Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patientsNathalie Conrad, Andrew Judge, Dexter Canoy, et al.
Annals of the Rheumatic Diseases|October 2, 2013
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug useSusanna M Proudman, Michael J James, Llewellyn D Spargo, et al.
JAMA Cardiology|September 4, 2019
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 IndividualsNathalie Conrad, Andrew Judge, Dexter Canoy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2018
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of lifeTarek Bekfani, Pierpaolo Pellicori, Daniel Morris, et al.
European Journal of Heart Failure|July 30, 2019
Geographical location affects the levels and association of trimethylamine N-oxide with heart failure mortality in BIOSTAT-CHF: a post-hoc analysisYoshiyuki Yazaki, Andrea Salzano, Christopher P Nelson, et al.
Biochimica Et Biophysica Acta|July 24, 2007
Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophilsMireille St-Onge, Nicolas Flamand, Jordane Biarc, et al.
European Journal of Heart Failure|December 4, 2019
Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF studyJoão Pedro Ferreira, Wouter Ouwerkerk, Jasper Tromp, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
European Journal of Heart Failure|March 16, 2017
Predictors of short-term clinical response to cardiac resynchronization therapyCecilia Linde, William T Abraham, Michael R Gold, et al.
Heart (British Cardiac Society)|January 6, 2026
Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and WalesAndrew L Clark, Rumana Z Omar, Gareth Ambler, et al.
Pageof 67

Showing results (521-530 of 663) with videos related to

Sort By:
Pageof 67
Plos Medicine|May 22, 2019
Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patientsNathalie Conrad, Andrew Judge, Dexter Canoy, et al.
Annals of the Rheumatic Diseases|October 2, 2013
Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug useSusanna M Proudman, Michael J James, Llewellyn D Spargo, et al.
JAMA Cardiology|September 4, 2019
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 IndividualsNathalie Conrad, Andrew Judge, Dexter Canoy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2018
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of lifeTarek Bekfani, Pierpaolo Pellicori, Daniel Morris, et al.
European Journal of Heart Failure|July 30, 2019
Geographical location affects the levels and association of trimethylamine N-oxide with heart failure mortality in BIOSTAT-CHF: a post-hoc analysisYoshiyuki Yazaki, Andrea Salzano, Christopher P Nelson, et al.
Biochimica Et Biophysica Acta|July 24, 2007
Characterization of prostaglandin E2 generation through the cyclooxygenase (COX)-2 pathway in human neutrophilsMireille St-Onge, Nicolas Flamand, Jordane Biarc, et al.
European Journal of Heart Failure|December 4, 2019
Cardiovascular and non-cardiovascular death distinction: the utility of troponin beyond N-terminal pro-B-type natriuretic peptide. Findings from the BIOSTAT-CHF studyJoão Pedro Ferreira, Wouter Ouwerkerk, Jasper Tromp, et al.
European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.
European Journal of Heart Failure|March 16, 2017
Predictors of short-term clinical response to cardiac resynchronization therapyCecilia Linde, William T Abraham, Michael R Gold, et al.
Heart (British Cardiac Society)|January 6, 2026
Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and WalesAndrew L Clark, Rumana Z Omar, Gareth Ambler, et al.
Pageof 67